| For: | Zezos P, Papaioannou G, Nikolaidis N, Vasiliadis T, Giouleme O, Evgenidis N. Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation. World J Gastroenterol 2005; 11(48): 7639-7645 [PMID: 16437691 DOI: 10.3748/wjg.v11.i48.7639] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i48/7639.htm |
| Number | Citing Articles |
| 1 |
Alaa Abozied, Yousryeia A. Ahmed, Mostafa F. Mohammed Saleh, Hanan Galal, Wael A. Abbas. Assessment of Von Willebrand factor antigen and activity levels in inflammatory bowel diseases. The Egyptian Journal of Haematology 2021; 46(4) doi: 10.4103/ejh.ejh_68_21
|
| 2 |
Martino Pepe, Eugenio Carulli, Cinzia Forleo, Marco Moscarelli, Ottavio Di Cillo, Alessandro Santo Bortone, Palma Luisa Nestola, Giuseppe Biondi-Zoccai, Arturo Giordano, Stefano Favale. Inflammatory Bowel Disease and Acute Coronary Syndromes: From Pathogenesis to the Fine Line Between Bleeding and Ischemic Risk. Inflammatory Bowel Diseases 2021; 27(5) doi: 10.1093/ibd/izaa160
|
| 3 |
Xia Wang, Fengyun Dong, Fufang Wang, Suhua Yan, Xiaocui Chen, Hideto Tozawa, Toshiyuki Ushijima, Carolyn M. Kapron, Youichiro Wada, Ju Liu. Low dose cadmium upregulates the expression of von Willebrand factor in endothelial cells. Toxicology Letters 2018; 290 doi: 10.1016/j.toxlet.2018.03.020
|
| 4 |
Katelynn S. Madill-Thomsen, Jeffery M. Venner, Denise E. Parsons, Konrad S. Famulski, Aducio L. Thiesen, Sami Hoque, Karen I. Kroeker, Karen Wong, Farhad Peerani, Levinus A. Dieleman, Frank Hoentjen, Daniel C. Baumgart, Philip F. Halloran, Brendan P. Halloran. Relating the molecular phenotype of ulcerative colitis to the clinical course. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-90618-8
|
| 5 |
S. I. Barth, S. M. DeMonaco, B. J. Conner, P. B. S. Serpa, A. R. Wilkinson. Plasma ADAMTS13 activity in healthy dogs and dogs with chronic enteropathy. Journal of Small Animal Practice 2026; doi: 10.1111/jsap.70172
|
| 6 |
Johannes J.A. Auwerda, Pieter Sonneveld, Moniek P.M. de Maat, Frank W.G. Leebeek. Prothrombotic Coagulation Abnormalities in Patients with Paraprotein-Producing B-Cell Disorders. Clinical Lymphoma and Myeloma 2007; 7(7) doi: 10.3816/CLM.2007.n.027
|
| 7 |
Jérémy Lagrange, Muhammad Usman Ahmed, Djésia Arnone, Patrick Lacolley, Véronique Regnault, Laurent Peyrin-Biroulet, Cécile V Denis. Implications of von Willebrand Factor in Inflammatory Bowel Diseases: Beyond Bleeding and Thrombosis. Inflammatory Bowel Diseases 2024; 30(12) doi: 10.1093/ibd/izae142
|
| 8 |
Suraj Pratap, Aimee Foord. Concurrent Presentation of von Willebrand Disease and Inflammatory Bowel Disease—A Case Report and Literature Review. eJHaem 2026; 7(2) doi: 10.1002/jha2.70246
|
| 9 |
Dae Sung Kim, Won Moon. Coagulopathy and platelet abnormalities in patients with inflammatory bowel disease. The Korean Journal of Internal Medicine 2025; 40(6) doi: 10.3904/kjim.2025.118
|
| 10 |
Mizuho Nosaka, Yuko Ishida, Aki Tanaka, Takahito Hayashi, Tomoko Miyashita, Chikako Kaminaka, Wolfgang Eisenmenger, Fukumi Furukawa, Akihiko Kimura. Aberrant Expression of Histo-blood Group A Type 3 Antigens in Vascular Endothelial Cells in Inflammatory Sites. Journal of Histochemistry & Cytochemistry 2008; 56(3) doi: 10.1369/jhc.7A7290.2007
|
| 11 |
Petros Zezos, Georgios Kouklakis, Fred Saibil. Inflammatory bowel disease and thromboembolism. World Journal of Gastroenterology 2014; 20(38): 13863-13878 doi: 10.3748/wjg.v20.i38.13863
|
| 12 |
Elise S. Eerenberg, Paul F.A. Teunissen, Bert-Jan van den Born, Joost C.M. Meijers, Maurits R. Hollander, Matthijs Jansen, Ruben Tijssen, Jeroen A.M. Beliën, Peter M. van de Ven, Mohamed F. Aly, Otto Kamp, Hans W. Niessen, Pieter Willem Kamphuisen, Marcel Levi, Niels van Royen. The role of ADAMTS13 in acute myocardial infarction: cause or consequence?. Cardiovascular Research 2016; 111(3) doi: 10.1093/cvr/cvw097
|
| 13 |
A. Kahlon, J. Grabell, A. Tuttle, D. Engen, W. Hopman, D. Lillicrap, P. James. Quantification of perioperative changes in von Willebrand factor and factor VIII during elective orthopaedic surgery in normal individuals. Haemophilia 2013; 19(5) doi: 10.1111/hae.12185
|
| 14 |
Jeremy Lagrange, Patrick Lacolley, Denis Wahl, Laurent Peyrin-Biroulet, Véronique Regnault. Shedding Light on Hemostasis in Patients With Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 2021; 19(6) doi: 10.1016/j.cgh.2019.12.043
|
| 15 |
Helen Close, James M. Mason, Douglas W. Wilson, A. Pali S. Hungin, Roger Jones, Greg Rubin, Giorgos Bamias. Risk of Ischaemic Heart Disease in Patients with Inflammatory Bowel Disease: Cohort Study Using the General Practice Research Database. PLOS ONE 2015; 10(10) doi: 10.1371/journal.pone.0139745
|
| 16 |
Andrea Boccatonda, Marco Balletta, Susanna Vicari, Ariela Hoxha, Paolo Simioni, Elena Campello. The Journey Through the Pathogenesis and Treatment of Venous Thromboembolism in Inflammatory Bowel Diseases: A Narrative Review. Seminars in Thrombosis and Hemostasis 2023; 49(07) doi: 10.1055/s-0042-1758869
|
| 17 |
Dana N. LeVine, Rachel E. Cianciolo, Keith E. Linder, Petra Bizikova, Adam J. Birkenheuer, Marjory B. Brooks, Abdelghaffar K. Salous, Shila K. Nordone, Dwight A. Bellinger, Henry Marr, Sam L. Jones, Thomas H. Fischer, Yu Deng, Marshall Mazepa, Nigel S. Key. Endothelial alterations in a canine model of immune thrombocytopenia. Platelets 2019; 30(1) doi: 10.1080/09537104.2017.1378807
|
| 18 |
Gerard Gurumurthy, Jecko Thachil. Thrombotic complications of glucocorticoids and anabolic steroids. Research and Practice in Thrombosis and Haemostasis 2025; 9(7) doi: 10.1016/j.rpth.2025.103208
|
| 19 |
Xia Wang, Junyu Zhao, Yong Zhang, Xiujuan Xue, Jie Yin, Lin Liao, Cuiping Xu, Yinglong Hou, Suhua Yan, Ju Liu. Kinetics of plasma von Willebrand factor in acute myocardial infarction patients: a meta-analysis. Oncotarget 2017; 8(52) doi: 10.18632/oncotarget.20091
|
| 20 |
Mahmoud A. Hafez, Mohamed Talaat, Ahmad Yaman Kebbe, Abdelrahman Helmy, Abdelrahman M Makram. Bilateral total knee replacement for hemophilic arthropathy: a case report. BMC Musculoskeletal Disorders 2025; 26(1) doi: 10.1186/s12891-025-08611-1
|
| 21 |
Fengyun Dong, Xinghai Zhao, Jianning Wang, Xin Huang, Xiao Li, Liang Zhang, Haixin Dong, Fuhong Liu, Mengge Fan. Dihydroartemisinin inhibits the expression of von Willebrand factor by downregulation of transcription factor ERG in endothelial cells. Fundamental & Clinical Pharmacology 2021; 35(2) doi: 10.1111/fcp.12622
|
| 22 |
Adriana Ribas Andrade, Tania Rubia Flores da Rocha, Carmen Lucia Ortiz-Agostinho, Iêda Nishitokukado, Alexandre Sousa Carlos, Matheus Freitas Cardoso de Azevedo, Claudio Lioshi Hashimoto, Aderson Omar Moura Cintra Damião, Flair José Carrilho, Elbio D’Amico, Aytan Miranda Sipahi, André Zonetti de Arruda Leite. Endoscopic activity, tissue factor and Crohn’s disease: findings in clinical remission patients. Therapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284820939412
|
| 23 |
Anahita Mojiri, Parnian Alavi, Nadia Jahroudi. Von Willebrand factor contribution to pathophysiology outside of von Willebrand disease. Microcirculation 2019; 26(4) doi: 10.1111/micc.12510
|
| 24 |
Huseyin Alkim, Selime Ayaz, Canan Alkim, Aysel Ulker, Burhan Sahin. Continuous Active State of Coagulation System in Patients With Nonthrombotic Inflammatory Bowel Disease. Clinical and Applied Thrombosis/Hemostasis 2011; 17(6) doi: 10.1177/1076029611405034
|
| 25 |
A. Di Sabatino, C. Ambaglio, N. Aronico, N. Ghidelli, M. V. Lenti, G. Gamba, G. R. Corazza. Acquired von Willebrand syndrome in inflammatory bowel disease. Haemophilia 2017; 23(3) doi: 10.1111/hae.13209
|
| 26 |
Pedro Emilio Bermejo, Aurora Burgos. Complicaciones neurológicas de la enfermedad inflamatoria intestinal. Medicina Clínica 2008; 130(17) doi: 10.1157/13120693
|
| 27 |
Muhammad Usman Ahmed, Laurent Peyrin-Biroulet, Jérémy Lagrange. Platelets in Disease: Thrombotic Disorders and Disorders not Involving Hemorrhage or Thrombosis. Platelets in Thrombotic and Non-Thrombotic Disorders 2025; doi: 10.1007/978-3-031-96352-0_24
|